Campbell & Co Investment Adviser’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Campbell & Co Investment Adviser's HALO Position: Q2 2026 in Review
Campbell & Co Investment Adviser opened a new position in Halozyme (HALO) in Q2 2026: 44,702 shares worth $3.5M. The stake represents 0.18% of the portfolio and ranks #154 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in HALO as recently as Q4 2025.
Campbell & Co Investment Adviser first reported a position in HALO in Q2 2013 and has held it in 22 quarters since. The position peaked at $6.51M in Q1 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Campbell & Co Investment Adviser held 44,702 shares of Halozyme worth $3.5M as of Q2 2026.
- Halozyme was a new Campbell & Co Investment Adviser position in Q2 2026.
- Halozyme made up 0.18% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #154 holding.
- Campbell & Co Investment Adviser first reported a position in Halozyme in Q2 2013 and has held it in 22 quarters since.
- Campbell & Co Investment Adviser's Halozyme position peaked at $6.51M in Q1 2025.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.